Recent analyst price targets cluster well above the current price but vary considerably. Bullish notes include Citi at $430 from October 2026, Stifel at $460 also in October, JPMorgan at $465, and Fubon Securities at $500 from September. More measured views come from TD Cowen at $225 with a Hold rating, Susquehanna at $258 Neutral, and UBS at $290 Neutral. Northland moved to Market Perform on valuation concerns, while BMO Capital started with Outperform and a $375 target, describing ALAB as a critical AI networking leader.
Averaging these verified targets yields a central figure near $380, within a broad range of roughly $190 to $500. The dispersion highlights differing views on how much AI infrastructure growth is already reflected in the price. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Bulls focus on rising content per AI accelerator, while skeptics highlight a forward P/E near 36 times and enterprise value above 25 times revenue at the peak. No single target should be viewed as certain.
Shares closed at $190.71 on Nov. 6, 2026, after falling from the 52-week high of about $499.48; the 52-week low sits near $97.89. A move to $380 would represent upside of roughly 99%, a substantial advance even for a high-growth semiconductor company. Achieving that would likely depend on continued triple-digit revenue growth, further Scorpio adoption, and either multiple expansion or earnings growth sufficient to support the valuation.
Astera's fundamentals remain strong. The company reported third-quarter revenue of about $584.9 million, up roughly 154% year over year, and guided fourth-quarter revenue to $730–$750 million. Full-year 2026 revenue is estimated near $1.91 billion, up about 124%, with 2027 estimates near $2.98 billion. Analysts point to rising content per GPU/XPU accelerator as AI clusters expand, deep ties with NVIDIA (NVDA) and Amazon (AMZN), and growth beyond connectivity into switching.
Valuation stands as the main hurdle. At its peak the stock traded near 36 times forward earnings and more than 25 times enterprise value to revenue, leaving little margin for shortfalls. Customer concentration is notable—Barclays has estimated Amazon alone could generate more than $3 billion in annual revenue for Astera. Competition from Broadcom (AVGO) and Marvell (MRVL), the shift from copper to optical, any slowdown in hyperscaler spending, and the stock's high beta all pose risks. A guidance miss or multiple compression could leave shares well below $380.
The stock's pattern shows a sharp round trip: a rally toward $499, a drop of roughly 60% to the low $190s, and an attempted recovery. The $177–$190 zone now serves as near-term support after the early-November low, while psychological resistance lies near $250–$260 and $300. Reaching toward $380 would require reclaiming those levels and rebuilding momentum above the prior breakdown point.
Analyst targets generally reflect a roughly 12-month horizon, though individual firms differ. Investors should track quarterly earnings and guidance, Scorpio adoption and content-per-accelerator metrics, hyperscaler capital-expenditure updates, analyst target revisions, and any regulatory or macro changes affecting AI infrastructure. Given the volatility, estimate revisions can matter as much as headline results.
The $380 central target, derived from the average of recent analyst price targets, implies roughly a doubling from the early-November share price—a very large move. The supporting case rests on exceptional revenue growth, rising AI-connectivity content, and a broadening product portfolio. The opposing case centers on valuation, customer concentration, and high volatility. With analyst targets spanning roughly $190 to $500, disagreement remains wide, and no outcome is guaranteed. Investors should focus on execution, guidance, and valuation rather than any single price forecast.
In my own workflow I frequently review Tickeron's AI Daily Buy/Sell Signals to stay on top of fast-moving names. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals drawn from market conditions, technical behavior, and AI-driven analysis. For a volatile stock like Astera Labs, these signals help separate noise from meaningful trend shifts without replacing careful fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
ALAB moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend. In 9 of 9 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALAB as a result. In 36 of 44 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ALAB turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 29 similar instances when the indicator turned negative. In 23 of the 29 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
The 10-day moving average for ALAB crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for ALAB entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALAB's RSI Oscillator exited the oversold zone, 12 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +20.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALAB advanced for three days, in 148 of 167 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
ALAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. ALAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALAB's P/B Ratio (19.172) is very high in comparison to the industry average of (5.443). P/E Ratio (87.885) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (40.650) is also within normal values, averaging (46.468).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors